Close Menu

NEW YORK (GenomeWeb) – A plan for regulating laboratory-developed tests that a group of diagnostic manufacturers and labs had penned two years ago has resurfaced in the US House of Representatives with backing from a Republican and Democratic legislator.

Representative Larry Bucshon (R-IN) and Diana DeGette (D-CO) publicly released the discussion draft (see PDF below) of the so-called Diagnostic Accuracy and Innovation Act, which is fashioned closely after a framework developed by the so-called Diagnostic Test Working Group in 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.